← Back to INMB

INmune Bio Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 30/10/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 30/10/2025Jun 2024Filed 30/10/2025Mar 2024Filed 30/10/2025
$0.1$0
−$1.3−$5.4−$6.5−$24−$9.7−$12−$9.7−$11
−$0.05−$0.20−$0.24−$1.05−$0.43−$0.60−$0.50−$0.61
2727272322201918

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.